Withanolides: Biologically Active Constituents in the Treatment of Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|12|3|238-256

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.12, Iss.3, 2016-05, pp. : 238-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Evaluation of memantine for the treatment of Alzheimer’s disease

By Ferris Steven H  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2305-2313

Informa Healthcare

Access to resources Recommend Favorite

The pharmacology of donepezil: a new treatment for Alzheimer’s disease

By Wilkinson D.G.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 121-135

Informa Healthcare

Access to resources Recommend Favorite

Emerging strategies for the treatment of Alzheimer’s disease at the Millennium

By Emmerling M.R.   Spiegel K.   D Hall E.   LeVine H.   Walker L.C.   Schwarz R.D.   Gracon S.  

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 35-86

Informa Healthcare

Access to resources Recommend Favorite

Future directions in the treatment of Alzheimer’s disease

By Bullock Roger  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 303-314

Informa Healthcare

Access to resources Recommend Favorite